Description
Ingredients:
Gliclazide mr 30mg (Modified Release).
Direction of Use:
Take as directed by a physician, preferably before meals. Swallow whole with water; do not crush or chew.
Indication:
Used for the treatment of type 2 diabetes mellitus, helping to control blood sugar levels when diet and exercise alone are insufficient.
Pharmacology, Dosage & Administration:
Gliclazide is a sulfonylurea that stimulates insulin secretion from the pancreas, improving blood sugar control.
Dosage: Typically 30-120 mg once daily, as prescribed by a doctor.
Interaction:
May interact with beta-blockers, NSAIDs, corticosteroids, and alcohol, affecting blood sugar levels.
Increased risk of hypoglycemia when combined with other antidiabetic medications or insulin.
Contraindications:
Type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment.
Hypersensitivity to Gliclazide or sulfonylureas.
Side Effects:
Common: Hypoglycemia (low blood sugar), dizziness, nausea, headache, weight gain.
Rare: Skin rash, liver dysfunction, or blood disorders.
Pregnancy & Lactation:
Not recommended during pregnancy; insulin is preferred.
Should be avoided during breastfeeding as it may pass into breast milk.
Precautions & Warnings:
Regularly monitor blood sugar levels.
Avoid alcohol as it may increase the risk of hypoglycemia.
Use cautiously in patients with kidney or liver disease.
Overdose Effects:
Severe hypoglycemia, leading to sweating, tremors, confusion, or unconsciousness. Immediate glucose intake or medical help is needed.
Therapeutic Class:
Sulfonylurea (Oral Hypoglycemic Agent).
Storage Conditions:
Store in a cool, dry place, away from direct sunlight and moisture.
Keep out of reach of children.
Reviews
There are no reviews yet.